KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Shares Outstanding (2016 - 2025)

Precigen (PGEN) has disclosed Shares Outstanding for 15 consecutive years, with $353.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 20.84% to $353.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $353.9 million through Dec 2025, up 20.84% year-over-year, with the annual reading at $353.9 million for FY2025, 20.84% up from the prior year.
  • Shares Outstanding for Q4 2025 was $353.9 million at Precigen, roughly flat from $353.8 million in the prior quarter.
  • The five-year high for Shares Outstanding was $353.9 million in Q4 2025, with the low at $206.4 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $253.2 million, with a median of $251.5 million recorded in 2024.
  • The sharpest move saw Shares Outstanding grew 23.18% in 2023, then dropped 2.05% in 2024.
  • Over 5 years, Shares Outstanding stood at $206.7 million in 2021, then grew by 0.68% to $208.2 million in 2022, then rose by 19.59% to $248.9 million in 2023, then grew by 17.66% to $292.9 million in 2024, then grew by 20.84% to $353.9 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $353.9 million, $353.8 million, and $297.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.